Molecular Mechanisms of Insulin Resistance Development
Insulin resistance (IR) is a phenomenon associated with an impaired ability of insulin to stimulate glucose uptake by target cells and to reduce the blood glucose level. A response increase in insulin secretion by the pancreas and hyperinsulinemia are compensatory reactions of the body. The developm...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b241062810944dc19909e8bbc4ce26cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b241062810944dc19909e8bbc4ce26cf |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b241062810944dc19909e8bbc4ce26cf2021-11-14T09:00:19ZMolecular Mechanisms of Insulin Resistance Development2072-03512072-037810.14341/DM2014229-40https://doaj.org/article/b241062810944dc19909e8bbc4ce26cf2014-07-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6597https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Insulin resistance (IR) is a phenomenon associated with an impaired ability of insulin to stimulate glucose uptake by target cells and to reduce the blood glucose level. A response increase in insulin secretion by the pancreas and hyperinsulinemia are compensatory reactions of the body. The development of IR leads to the inability of target cells to respond to insulin that results in developing type 2 diabetes mellitus (T2DM) and metabolic syndrome. For this reason, the metabolic syndrome is defined in practice as a combination of IR with one or more pathologies such as T2DM, arterial hypertension, dyslipidemia, abdominal obesity, non-alcoholic fatty liver disease, and some others. However, a combination of high blood glucose and insulin levels always serves as its physiological criterion. IR should be considered as a systemic failure of the endocrine regulation in the body. Physiological causes of IR are diverse. The main ones are nutritional overload and accumulation of certain lipids and their metabolites in cells, low physical activity, chronic inflammation and stress of various nature, including oxidative and endoplasmic reticulum stress (impairment of damaged protein degradation in the cell). Recent studies have demonstrated that these physiological mechanisms likely act through a single intracellular scenario. This is the impairment of signal transduction from the insulin receptor to its targets via the negative feedback mechanism in intracellular insulin-dependent signaling cascades. This review describes the physiological and intracellular mechanisms of insulin action and focuses on their abnormalities upon IR development. Finally, feasible trends in early molecular diagnosis and therapy of IR are discussed.Vsevolod Arsen'evich TkachukAlexander Vyacheslavovich VorotnikovEndocrinology Research Centrearticleinsulin resistancetype 2 diabetes mellitusinsulin-dependent intracellular signalingfeedbackirs proteinphosphor?ylationNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 17, Iss 2, Pp 29-40 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
insulin resistance type 2 diabetes mellitus insulin-dependent intracellular signaling feedback irs protein phosphor?ylation Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
insulin resistance type 2 diabetes mellitus insulin-dependent intracellular signaling feedback irs protein phosphor?ylation Nutritional diseases. Deficiency diseases RC620-627 Vsevolod Arsen'evich Tkachuk Alexander Vyacheslavovich Vorotnikov Molecular Mechanisms of Insulin Resistance Development |
description |
Insulin resistance (IR) is a phenomenon associated with an impaired ability of insulin to stimulate glucose uptake by target cells and to reduce the blood glucose level. A response increase in insulin secretion by the pancreas and hyperinsulinemia are compensatory reactions of the body. The development of IR leads to the inability of target cells to respond to insulin that results in developing type 2 diabetes mellitus (T2DM) and metabolic syndrome. For this reason, the metabolic syndrome is defined in practice as a combination of IR with one or more pathologies such as T2DM, arterial hypertension, dyslipidemia, abdominal obesity, non-alcoholic fatty liver disease, and some others. However, a combination of high blood glucose and insulin levels always serves as its physiological criterion. IR should be considered as a systemic failure of the endocrine regulation in the body. Physiological causes of IR are diverse. The main ones are nutritional overload and accumulation of certain lipids and their metabolites in cells, low physical activity, chronic inflammation and stress of various nature, including oxidative and endoplasmic reticulum stress (impairment of damaged protein degradation in the cell). Recent studies have demonstrated that these physiological mechanisms likely act through a single intracellular scenario. This is the impairment of signal transduction from the insulin receptor to its targets via the negative feedback mechanism in intracellular insulin-dependent signaling cascades. This review describes the physiological and intracellular mechanisms of insulin action and focuses on their abnormalities upon IR development. Finally, feasible trends in early molecular diagnosis and therapy of IR are discussed. |
format |
article |
author |
Vsevolod Arsen'evich Tkachuk Alexander Vyacheslavovich Vorotnikov |
author_facet |
Vsevolod Arsen'evich Tkachuk Alexander Vyacheslavovich Vorotnikov |
author_sort |
Vsevolod Arsen'evich Tkachuk |
title |
Molecular Mechanisms of Insulin Resistance Development |
title_short |
Molecular Mechanisms of Insulin Resistance Development |
title_full |
Molecular Mechanisms of Insulin Resistance Development |
title_fullStr |
Molecular Mechanisms of Insulin Resistance Development |
title_full_unstemmed |
Molecular Mechanisms of Insulin Resistance Development |
title_sort |
molecular mechanisms of insulin resistance development |
publisher |
Endocrinology Research Centre |
publishDate |
2014 |
url |
https://doaj.org/article/b241062810944dc19909e8bbc4ce26cf |
work_keys_str_mv |
AT vsevolodarsenevichtkachuk molecularmechanismsofinsulinresistancedevelopment AT alexandervyacheslavovichvorotnikov molecularmechanismsofinsulinresistancedevelopment |
_version_ |
1718429551316434944 |